Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma
- PMID: 23644492
- DOI: 10.1038/ng.2638
Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma
Abstract
We conducted a genome-wide scan of SNPs to identify variants associated with length of survival in 1,331 individuals with esophageal squamous-cell carcinoma (ESCC), with associations validated in 2 independent sets including 1,962 individuals with this cancer. We identified rs1050631 in SLC39A6 as associated with the survival times of affected individuals, with the hazard ratio for death from ESCC in the combined sample being 1.30 (95% confidence interval (CI) = 1.19-1.43; P = 3.77 × 10(-8)). rs7242481, located in the 5' UTR of SLC39A6, disturbs a transcriptional repressor binding site and results in upregulation of SLC39A6 expression. Immunohistochemical staining of ESCC tissues showed that higher expression of SLC39A6 protein was correlated with shorter length of survival in individuals with advanced ESCC (P = 0.013). Knockdown of SLC39A6 expression suppressed proliferation and invasion in ESCC cells. These results suggest that SLC39A6 has an important role in the prognosis of ESCC and may be a potential therapeutic _target.
Similar articles
-
Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.Gastroenterology. 2017 Jun;152(8):1985-1997.e12. doi: 10.1053/j.gastro.2017.02.006. Epub 2017 Feb 14. Gastroenterology. 2017. PMID: 28209530
-
SLC39A6: a potential _target for diagnosis and therapy of esophageal carcinoma.J Transl Med. 2015 Oct 6;13:321. doi: 10.1186/s12967-015-0681-z. J Transl Med. 2015. PMID: 26444413 Free PMC article.
-
Involvement of SLC39A6 in gastric adenocarcinoma and correlation of the SLC39A6 polymorphism rs1050631 with clinical outcomes after resection.BMC Cancer. 2019 Nov 8;19(1):1069. doi: 10.1186/s12885-019-6222-z. BMC Cancer. 2019. PMID: 31703635 Free PMC article.
-
SLC39A6 affects esophageal squamous cell carcinoma survival.Cancer Discov. 2013 Jul;3(7):OF27. doi: 10.1158/2159-8290.CD-RW2013-102. Epub 2013 May 16. Cancer Discov. 2013. PMID: 23847371
-
RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.Int J Oncol. 2018 Mar;52(3):861-871. doi: 10.3892/ijo.2018.4253. Epub 2018 Jan 24. Int J Oncol. 2018. PMID: 29393393
Cited by
-
A genome wide association study on Newfoundland colorectal cancer patients' survival outcomes.Biomark Res. 2015 Mar 19;3:6. doi: 10.1186/s40364-015-0031-6. eCollection 2015. Biomark Res. 2015. PMID: 25866641 Free PMC article.
-
Zinc transporter ZIP10 forms a heteromer with ZIP6 which regulates embryonic development and cell migration.Biochem J. 2016 Aug 15;473(16):2531-44. doi: 10.1042/BCJ20160388. Epub 2016 Jun 7. Biochem J. 2016. PMID: 27274087 Free PMC article.
-
Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China.J Cancer. 2019 Jun 9;10(16):3624-3631. doi: 10.7150/jca.32810. eCollection 2019. J Cancer. 2019. PMID: 31333779 Free PMC article.
-
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4. Gut. 2018. PMID: 28779025 Free PMC article.
-
BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.Onco_target. 2017 May 30;8(22):36033-36039. doi: 10.18632/onco_target.16422. Onco_target. 2017. PMID: 28415599 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical